The C-terminal flanking peptide (CTFP) of progastrin inhibits apoptosis via a PI3-kinase-dependent pathway.

Regul Pept 2010 Dec 19;165(2-3):224-31. Epub 2010 Aug 19.

Department of Surgery, University of Melbourne Austin Health, Melbourne, Victoria 3084, Australia.

Progastrin is processed to a number of peptides including glycine-extended gastrin, amidated gastrin and the C-terminal flanking peptide (CTFP). Progastrin and gastrin-gly are pro-proliferative and anti-apoptotic in gastric and colorectal cancer cell lines. The CTFP is a major form of progastrin in the stomach and colon and stimulates proliferation. However the effect of CTFP on apoptosis has not been examined. Using the human gastric carcinoma cell line AGS we show that CTFP attenuates apoptosis through a PI3-kinase pathway by stimulating the phosphorylation of Akt leading to sustained increases in the concentrations of Bcl-xL and phosphorylated Bad protein and by reducing caspase 3 activity. The anti-apoptotic effect represents an important potential mechanism for the growth promoting action of CTFP.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.regpep.2010.08.005DOI Listing
December 2010

Publication Analysis

Top Keywords

flanking peptide
8
ctfp progastrin
8
c-terminal flanking
8
peptide ctfp
8
ctfp
6
lines ctfp
4
activity anti-apoptotic
4
cell lines
4
caspase activity
4
ctfp attenuates
4
major form
4
cancer cell
4
ctfp major
4
attenuates apoptosis
4
anti-apoptotic gastric
4
bcl-xl phosphorylated
4
anti-apoptotic represents
4
gastric colorectal
4
colorectal cancer
4
form progastrin
4

Similar Publications